Table 3.
Clinical data of patients in hypertension group and non-hypertension group
| Clinical data | HT group | Non-HT group | t/U/χ2 | P |
|---|---|---|---|---|
| Sex (M/F) | 9/4 | 28/26 | 1.28 | 0.258 |
| Age (y) | 61.9±11 | 41.1±15.7 | -4.505 | 0.000* |
| TPNT | 25.5±9.5 | 16.7±7.9 | -3.473 | 0.001* |
| Clinical types | 2.301 | 0.317 | ||
| Mild | 2 | 19 | ||
| Moderate | 9 | 31 | ||
| Severe | 2 | 4 | ||
| Complications | ||||
| Bacterial infection | 4/9 | 2/52 | 9.414 | 0.002* |
| Diabetes | 3/10 | 4/50 | 2.75 | 0.097 |
| Treatment | ||||
| Abidol (Y/N) | 11/2 | 28/26 | 4.623 | 0.032* |
| Interferon (Y/N) | 12/1 | 46/8 | 0.457 | 0.499 |
| Thymosin (Y/N) | 5/8 | 11/43 | 1.886 | 0.17 |
| Glucocorticoid (Y/N) | 4/9 | 14/40 | 0.125 | 0.724 |
| Laboratory findings | ||||
| AST (U/L) | 36.9±32.4 | 25.9±9.5 | -2.174 | 0.033* |
| ALT (U/L) | 51.1±41.3 | 35.4±24.9 | -1.77 | 0.081 |
| LDH (U/L) | 247.6±99.7 | 206.3±67 | -1.804 | 0.076 |
| Alb (g/L) | 40.3±8.2 | 44.3±4.2 | 2.497 | 0.015* |
| Glu (mmol/L) | 7.1±1.7 | 6.4±1.7 | -1.141 | 0.261 |
| TC (mmol/L) | 3.69 (2, 7) | 3.97 (3, 7) | -0.035 | 0.927 |
| TG (mmol/L) | 1.36 (0.85, 3.15) | 1.14 (0.57, 5.22) | 0.048 | 0.962 |
| WBC (109/L) | 5.7±1.7 | 5.3±2.1 | -0.603 | 0.548 |
| N (109/L) | 4.1±1.5 | 3.4±1.7 | -1.098 | 0.279 |
| L (109/L) | 1.1±0.5 | 1.5±0.9 | 1.474 | 0.145 |
| CRP (mg/L) | 16 (0.2, 174.6) | 6.8 (0, 142.4) | 1.237 | 0.216 |
| IL-6 (pg/ml) | 11.5 (3, 62) | 7 (2, 29) | 0.14 | 0.155 |
| Ferritin (ng/ml) | 678.7 (151, 1247) | 346.8 (39, 1848) | 0.338 | 0.367 |
| NLR | 3.02 (1.45, 9.39) | 2.81 (1.12, 22.15) | 0.464 | 0.475 |
*
P<0.05.